NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
3-(3-oxo-2,3-dihydro-1H-indol-2-ylidene)-2,3-dihydro-1H-indol-2-one
|
|
|
IUPAC Traditional name
|
3-(3-oxo-1H-indol-2-ylidene)-1H-indol-2-one
|
|
|
Synonyms
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
7.41985
|
H Acceptors
|
3
|
H Donor
|
2
|
LogD (pH = 5.5)
|
2.429935
|
LogD (pH = 7.4)
|
2.1638434
|
Log P
|
2.434867
|
Molar Refractivity
|
78.9954 cm3
|
Polarizability
|
28.034647 Å3
|
Polar Surface Area
|
58.2 Å2
|
Rotatable Bonds
|
0
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Selleck Chemicals
Selleck Chemicals -
S2386
|
Research Area: Cancer Biological Activity: Indirubin is a potent cyclin-dependent kinases and GSK-3β inhibitor with IC50 of about 75 nM and 0.19 μM. It inhibits CDK5- and GSK-3β-mediated tau phosphorylation, a process over-active in Alzheimer disease states. Also inhibits AMPK, LCK and SGK. Induces cell cycle arrest and inhibits cell proliferation. It suppressed tumor necrosis factor (TNF)-induced NF-κB activation in a dose- and time-dependent manner. Indirubin also suppressed the NF-κB activation induced by various inflammatory agents and carcinogens. Further studies showed that indirubin blocked the phosphorylation and degradation of IκBα through the inhibition of activation of IκBα kinase and phosphorylation and nuclear translocation of p65. NF-κB reporter activity induced by TNFR1, TNF receptor-associated death domain, TRAF2, TAK1, NF-κB-inducing kinase, and IKKβ was inhibited by indirubin but not that induced by p65 transfection. [1][2]References on Indirubin[1] NATURE CELL BIOLOGY, MAY 1999, 1:60-67[2] THE JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276:251–260 |
PATENTS
PATENTS
PubChem Patent
Google Patent